FAKTOR-OPTIONSSCHEIN - DEXCOM Stock

DE000MA9VT45

Market Closed - Börse Stuttgart 15:51:26 2024-05-27 EDT
0.89 ^EUR	+1.14%

1 month	-4.30%
3 months	-39.86%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Latest news about DEXCOM, INC.

Declaration of Voting Results by DexCom, Inc	05-24	CI
Declaration of Voting Results by DexCom, Inc	05-24	CI
Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes	05-20	BU
DexCom : Human Rights Statement	05-08	PU

More news

Quotes 5-day view

Date	Price	Change
24-05-27	0.89	+1.14%
24-05-24	0.88	-4.35%
24-05-23	0.92	+12.20%
24-05-22	0.82	0.00%
24-05-21	0.82	-1.20%

Delayed Quote Börse Stuttgart

Last update May 27, 2024 at 03:51 pm

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	DEXCOM, INC.
Issuer	Morgan Stanley
WKN	MA9VT4
ISIN	DE000MA9VT45
Date issued	2021-11-04
Strike	169.9 $
Maturity	Unlimited
Parity	44.43 : 1
Emission price	10 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	48.14 €
Lowest since issue	0.68 €
Spread	0.03 €
Spread %	3.26%

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

127.4 USD

Average target price

151.2 USD

Spread / Average Target

+18.73%

Consensus